Sevirumab (MSL-109), a human IgG1 monoclonal antibody, neutralizes cytomegalovirus (CMV) by specifically targeting CMV gH complexes, effectively inhibiting viral replication with an EC50 value of 0.3 µg/mL [1] [2].
CAS Number:
[138660-96-5]
* VAT and and shipping costs not included. Errors and price changes excepted
